Literature DB >> 8083364

Gene expression, localization, and characterization of endothelin A and B receptors in the human adrenal cortex.

G Rossi1, G Albertin, A Belloni, L Zanin, M A Biasolo, T Prayer-Galetti, M Bader, G G Nussdorfer, G Palù, A C Pessina.   

Abstract

Compelling evidence indicates that the endothelium-derived potent vasoconstrictor endothelin-1 (ET-1) stimulates aldosterone secretion by interacting with specific receptors. Although two different ET-1 receptors have been identified and cloned, the receptor subtype involved in mediating aldosterone secretion is still unknown. Accordingly, we wished to investigate whether the genes of ET-1 and of its receptors A and B are expressed in the normal human adrenal cortex. We designed specific primers for ET-1 and the ETA and ETB receptors genes and developed a reverse transcription polymerase chain reaction (RT-PCR) with chemiluminescent quantitation of the cDNA. In addition, we carried out 125I ET-1 displacement studies with cold ET-1, ET-3 and the specific ETA and ETB ligands BQ123 and sarafotoxin 6C. Localization of each receptor subtype was also investigated by autoradiography. Binding experiments were first individually analyzed by Scatchard and Hofstee plot and then coanalyzed by the nonlinear iterative curve fitting program Ligand. Histologically normal adrenal cortex tissue, obtained from kidney cancer patients (n = 7), and an aldosterone-producing adenoma (APA), which is histogenetically derived from the zona glomerulosa (ZG) cells, were studied. Results showed that the ET-1, ETA and ETB mRNA can be detected by RT-PCR in all adrenal cortices as well as in the APA. The best fitting of the 125I ET-1 displacement binding data was consistently provided by a two-site model both in the normal adrenal cortex (F = 22.1, P < 0.0001) and in the APA (F = 18.4, P < 0.0001). In the former the density (Bmax) of the ETA and ETB subtype was 2.6 +/- 0.5 pmol/mg protein (m +/- SEM) and 1.19 +/- 0.6, respectively. The dissociation constant (Kd) of ET-1, ET-3, S6C, and BQ-123 for each receptor subtype resulted to be within the range reported for human tissue for the ETA and ETB receptors. In the APA tissue the Bmax tended to be lower (1.33 and 0.8 pmol/mg protein, for the ETA and ETB, respectively) but the Kd were similar. Autoradiographic studies confirmed the presence of both receptor subtypes on the ZG as well as on APA cells. Thus, the genes of ET-1 and both its receptor subtypes ETA and ETB are actively transcribed in the human adrenal cortex. Furthermore, both receptor subtypes are translated into proteins in ZG and APA cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083364      PMCID: PMC295207          DOI: 10.1172/JCI117440

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

1.  Integrated cardiac, renal, and endocrine actions of endothelin.

Authors:  W L Miller; M M Redfield; J C Burnett
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide?

Authors:  C Koseki; M Imai; Y Hirata; M Yanagisawa; T Masaki
Journal:  Am J Physiol       Date:  1989-04

3.  Endothelin enhances adrenocorticotropin-stimulated aldosterone release from cultured bovine adrenal cells.

Authors:  L J Rosolowsky; W B Campbell
Journal:  Endocrinology       Date:  1990-04       Impact factor: 4.736

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  Endothelin sensitivity and receptor binding in the aorta of spontaneously hypertensive rats.

Authors:  M Clozel
Journal:  J Hypertens       Date:  1989-11       Impact factor: 4.844

6.  Cardiorenal actions of endothelin, Part I: Effects of converting enzyme inhibition.

Authors:  L Q Cao; R O Banks
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

7.  Endothelin receptor subtypes and stimulation of aldosterone secretion.

Authors:  C E Gomez-Sanchez; E N Cozza; M F Foecking; S Chiou; M W Ferris
Journal:  Hypertension       Date:  1990-06       Impact factor: 10.190

8.  Mechanisms involved in the stimulation of aldosterone production by angiotensin II, vasopressin and endothelin.

Authors:  E A Woodcock; J K Tanner; L M Caroccia; P J Little
Journal:  Clin Exp Pharmacol Physiol       Date:  1990-04       Impact factor: 2.557

9.  Plasma endothelin levels in hypertension and chronic renal failure.

Authors:  M Shichiri; Y Hirata; K Ando; T Emori; K Ohta; S Kimoto; M Ogura; A Inoue; F Marumo
Journal:  Hypertension       Date:  1990-05       Impact factor: 10.190

10.  Stable expression of human endothelin receptors ETA and ETB by transfected baby hamster kidney cells.

Authors:  U Hechler; A Becker; B Haendler; W D Schleuning
Journal:  Biochem Biophys Res Commun       Date:  1993-08-16       Impact factor: 3.575

View more
  9 in total

Review 1.  Hemodynamic effects of bosentan in patients with chronic heart failure.

Authors:  W Kiowski; G Sütsch; E Oechslin; O Bertel
Journal:  Heart Fail Rev       Date:  2001-12       Impact factor: 4.214

Review 2.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

3.  Differential distribution of endothelin peptides and receptors in human adrenal gland.

Authors:  A P Davenport; S L Hoskins; R E Kuc; C Plumpton
Journal:  Histochem J       Date:  1996-11

Review 4.  Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

5.  Role of Ca2+ in the action of adrenocorticotropin in cultured human adrenal glomerulosa cells.

Authors:  N Gallo-Payet; E Grazzini; M Côté; L Chouinard; A Chorvátová; L Bilodeau; M D Payet; G Guillon
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.

Authors:  M A Biasolo; A Radaelli; L Del Pup; E Franchin; C De Giuli-Morghen; G Palu
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.

Authors:  Maniselvan Kuppusamy; Brasilina Caroccia; Julia Stindl; Sascha Bandulik; Livia Lenzini; Francesca Gioco; Veniamin Fishman; Giuseppe Zanotti; Celso Gomez-Sanchez; Michael Bader; Richard Warth; Gian Paolo Rossi
Journal:  J Clin Endocrinol Metab       Date:  2014-07-24       Impact factor: 5.958

Review 8.  Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism.

Authors:  Hervé Lefebvre; Céline Duparc; Gaëtan Prévost; Jérôme Bertherat; Estelle Louiset
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-20       Impact factor: 5.555

Review 9.  Role of ACTH in the Interactive/Paracrine Regulation of Adrenal Steroid Secretion in Physiological and Pathophysiological Conditions.

Authors:  Hervé Lefebvre; Michaël Thomas; Céline Duparc; Jérôme Bertherat; Estelle Louiset
Journal:  Front Endocrinol (Lausanne)       Date:  2016-07-20       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.